Samsca OD tablet 30mg, manufactured by Otsuka Pharmaceutical, contains tolvaptan, a selective vasopressin V2-receptor antagonist. It is indicated for the treatment of hyponatremia and rapidly enlarging autosomal dominant polycystic kidney disease (ADPKD). (YJ code: 2499012F2029, Standard: 30mg 1 tablet)
Samsca OD tablet 30mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
